CAR-T 细胞疗法是癌症治疗领域的一项重大突破，也是基因工程细胞作为治疗手段的有力证明。除了已获批准用于白血病等血液类癌症治疗以外，CAR-T 细胞疗法还在实体瘤、自身免疫疾病以及组织再生方面也展现出巨大潜力。 然而，大量临床试验显示，CAR-T 细胞 ...

本综述系统阐述了CRISPR/Cas9及其衍生技术碱基编辑（Base Editing）和引导编辑（Prime Editing）在植物性状改良中的突破性进展 ...

When the genome-editing tool CRISPR is thought of as a potential medicine, the targets that first come to mind are diseases like sickle cell or other conditions caused by particular mutations. Use ...

麻省总医院布莱根分校（Mass General Brigham）和麻省理工学院-哈佛大学布罗德研究所（Broad Institute）的研究人员发现了可以提高嵌合抗原受体（CAR）-T细胞疗法疗效的基因修饰。CAR-T细胞疗法是一种利用经过修饰的患者T细胞靶向癌症的免疫疗法。该研究利用CRISPR ...

The practice of genetic modification is as old as humanity. For thousands of years, humans have bred crops, livestock and even pets that possess desirable traits. This selective process, which alters ...

The gene-editing technique known as CRISPR is promising to revolutionize medicine. Some researchers are trying to help make it available for people with very rare genetic disorders. A gene-editing ...

Personalized CRISPR cures for children born with rare genetic diseases are now a step closer to being more widely available. Today, the Chan Zuckerberg Initiative (CZI) and the Innovative Genomics ...

CRISPR has the power to correct genetic mutations, but current delivery methods are either unsafe or inefficient, keeping the technology from reaching its full medical potential. With the power to ...

Researchers are further improving CRISPR's versatility to engineer new grasses and yeasts for biochemical production. CRISPR/Cas systems have undergone tremendous advancement in the past decade. These ...

CRISPR Therapeutics (CRSP) just announced that its SyNTase gene editing technology will be featured in an oral presentation at the ESGCT 2025 Congress. This marks the first major public unveiling of ...